The content on this site is intended for healthcare professionals only
For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Jury still out on cardiovascular safety of prostate cancer treatments
Understanding and targeting prostate cancer metabolism
Study suggests adding the drug berzosertib to standard treatment for metastatic bladder cancer does ...
Biomarker identified that may help predict benefits of immunotherapy
FDA approves nivolumab for adjuvant treatment of urothelial carcinoma
One-half of patients with low-risk prostate cancer switch from active surveillance to active treatme...
Biomarkers of biochemical recurrence in prostate adenocarcinoma
Patients helping researchers to advance treatments for prostate cancer
Fear of cancer recurrence remains for certain prostate cancer survivors long after treatment